These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 30791220)

  • 21. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
    Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma.
    Sakugawa C; Haruyama Y; Tanaka H; Fukushima T; Kawaguchi M; Kataoka H
    BMC Res Notes; 2017 Dec; 10(1):674. PubMed ID: 29202869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma.
    Park SJ; Gu MJ; Lee DS; Yun SS; Kim HJ; Choi JH
    Int J Clin Exp Pathol; 2015; 8(7):8298-304. PubMed ID: 26339400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Characteristics of Pancreatic Ductal Adenocarcinomas with High-Grade Pancreatic Intraepithelial Neoplasia (PanIN) Are Different from Those without High-Grade PanIN.
    Miyazaki T; Ohishi Y; Miyasaka Y; Oda Y; Aishima S; Ozono K; Abe A; Nagai E; Nakamura M; Oda Y
    Pathobiology; 2017; 84(4):192-201. PubMed ID: 28291966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions.
    Funel N; Morelli M; Giovannetti E; Del Chiaro M; Pollina LE; Mosca F; Boggi U; Cavazzana A; Campani D
    Pancreatology; 2011; 11(1):30-42. PubMed ID: 21412023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mAb Das-1 identifies pancreatic ductal adenocarcinoma and high-grade pancreatic intraepithelial neoplasia with high accuracy.
    Das KK; Brown JW; Fernandez Del-Castillo C; Huynh T; Mills JC; Matsuda Y; Das KM; Mino-Kenudson M
    Hum Pathol; 2021 May; 111():36-44. PubMed ID: 33524436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance?
    Konstantinidis IT; Vinuela EF; Tang LH; Klimstra DS; D'Angelica MI; Dematteo RP; Kingham TP; Fong Y; Jarnagin WR; Allen PJ
    Ann Surg Oncol; 2013 Oct; 20(11):3643-7. PubMed ID: 23748606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells.
    Prasad NB; Biankin AV; Fukushima N; Maitra A; Dhara S; Elkahloun AG; Hruban RH; Goggins M; Leach SD
    Cancer Res; 2005 Mar; 65(5):1619-26. PubMed ID: 15753353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (PDAC).
    Zińczuk J; Zaręba K; Romaniuk W; Kamińska D; Nizioł M; Baszun M; Kędra B; Guzińska-Ustymowicz K; Pryczynicz A
    Int J Med Sci; 2019; 16(4):583-592. PubMed ID: 31171910
    [No Abstract]   [Full Text] [Related]  

  • 32. Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Yamazaki K; Masugi Y; Effendi K; Tsujikawa H; Hiraoka N; Kitago M; Shinoda M; Itano O; Tanabe M; Kitagawa Y; Sakamoto M
    Lab Invest; 2014 Jun; 94(6):683-91. PubMed ID: 24709776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.
    Nakata K; Ohuchida K; Nagai E; Hayashi A; Miyasaka Y; Kayashima T; Yu J; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
    Neoplasia; 2009 Jul; 11(7):712-9. PubMed ID: 19568416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment.
    Gomez-Chou SB; Swidnicka-Siergiejko AK; Badi N; Chavez-Tomar M; Lesinski GB; Bekaii-Saab T; Farren MR; Mace TA; Schmidt C; Liu Y; Deng D; Hwang RF; Zhou L; Moore T; Chatterjee D; Wang H; Leng X; Arlinghaus RB; Logsdon CD; Cruz-Monserrate Z
    Cancer Res; 2017 May; 77(10):2647-2660. PubMed ID: 28249896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.
    Stark AP; Chang HH; Jung X; Moro A; Hertzer K; Xu M; Schmidt A; Hines OJ; Eibl G
    Surgery; 2015 Dec; 158(6):1564-72. PubMed ID: 26297056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
    Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
    Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm.
    Yamaguchi J; Yokoyama Y; Kokuryo T; Ebata T; Enomoto A; Nagino M
    J Clin Invest; 2018 Aug; 128(8):3619-3629. PubMed ID: 29809170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
    Shi C; Hong SM; Lim P; Kamiyama H; Khan M; Anders RA; Goggins M; Hruban RH; Eshleman JR
    Mol Cancer Res; 2009 Feb; 7(2):230-6. PubMed ID: 19208745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer.
    Recouvreux MV; Moldenhauer MR; Galenkamp KMO; Jung M; James B; Zhang Y; Lowy A; Bagchi A; Commisso C
    J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32510550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.